Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 4/20 | 0.42 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.42 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.38 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | LOXL2 | Q9Y4K0 | 3/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | LOX | P28300 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21546126 | 1.00 | F10 (0.42) | F10SPHK2ITGB3ITGA2BKMT2A | |
| SCHEMBL13634584 | 1.00 | F10 (0.42) | F10SPHK2ITGB3ITGA2BKMT2A | |
| SCHEMBL25093166 | 0.94 | F10 (0.41) | F10SPHK2ITGB3ITGA2BKMT2A | |
| SCHEMBL19275855 | 0.93 | KMT2A (0.39) | F10ITGB3ITGA2BKMT2AMEN1 | |
| SCHEMBL24370727 | 0.91 | SMN1; SMN2 (0.45) | F10SPHK2ITGB3ITGA2BKMT2A | |
| SCHEMBL21538137 | 0.90 | KMT2A (0.39) | F10KMT2AMEN1TAAR1GAA | |
| SCHEMBL14611467 | 0.90 | SMN1; SMN2 (0.45) | KMT2AMEN1TAAR1GAAMAPT | |
| SCHEMBL13525981 | 0.90 | F10 (0.38) | F10SPHK2KMT2AMEN1TAAR1 | |
| SCHEMBL26167876 | 0.89 | LOX (0.43) | F10SPHK2ITGB3ITGA2BKMT2A | |
| SCHEMBL24199561 | 0.89 | F10 (0.40) | F10SPHK2ITGB3ITGA2BKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250215489-A1 | Method of Sequencing L-Polynucleotide | DXOME CO., LTD. (KR) | 2025-07-03 | — | — | US | disclosed |
| CN-119979309-A | Flow cell, sequencing kit and gene sequencing method | 郑州中科生物医学工程技术研究院 | 2025-05-13 | — | — | CN | disclosed |
| WO-2025072834-A2 | METHOD OF SEQUENCING AND SYNTHESIZING L-POLYNUCLEOTIDE | DXOME CO., LTD. (KR) | 2025-04-03 | — | — | WO | disclosed |
| EP-4496799-A2 | METHOD OF SEQUENCING L-POLYNUCLEOTIDE | Dxome Co., Ltd. (KR) | 2025-01-29 | — | — | EP | disclosed |
| WO-2023183345-A2 | METHOD OF SEQUENCING L-POLYNUCLEOTIDE | DXOME INC. (US) | 2023-09-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250215489-A1 | Method of Sequencing L-Polynucleotide | POLN, RNGTT, UNG | F10 2058/4885SPHK2 3909/4885ITGB3 4357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.